Lactational mastitis

Acute mastitis is usually associated with breastfeeding and is often caused by Staphylococcus aureus. Poor infant positioning, milk stasis and nipple damage are contributing factors. Breastfeeding or expressing milk (manually or via a pump) from the infected breast is safe and should be continued.

If mastitis is not associated with breastfeeding, seek expert advice for management.

In patients without systemic symptoms, increased breastfeeding and gently expressing milk from the affected breast may prevent progression and resolve infection without antibiotics.

In patients with systemic symptoms, or symptoms or signs that have not resolved after 24 to 48 hours of increased breastfeeding and expressing of milk, early antibiotic therapy is important to prevent abscess formation. Combine antibiotic therapy with increased breastfeeding and expressing of milk.

Use:

1 dicloxacillin 500 mg orally, 6-hourly. For dosage adjustment in adults with kidney impairment, see dicloxacillin dosage adjustment. If symptoms and signs resolve rapidly, 5 days of therapy may be sufficient; otherwise continue treatment for 10 days lactational mastitis dicloxacillin    

OR

1 flucloxacillin 500 mg orally, 6-hourly. For dosage adjustment in adults with kidney impairment, see flucloxacillin oral dosage adjustment. If symptoms and signs resolve rapidly, 5 days of therapy may be sufficient; otherwise continue treatment for 10 days. lactational mastitis flucloxacillin    

For patients who have had a nonsevere (immediate or delayed) hypersensitivity reaction to a penicillin1, use:

cefalexin 500 mg orally, 6-hourly. For dosage adjustment in adults with kidney impairment, see cefalexin dosage adjustment. If symptoms and signs resolve rapidly, 5 days of therapy may be sufficient; otherwise continue treatment for 10 days. lactational mastitis cefalexin    

For patients who have had a severe (immediate or delayed)2 hypersensitivity reaction to a penicillin, use:

clindamycin 450 mg orally, 8-hourly. If symptoms and signs resolve rapidly, 5 days of therapy may be sufficient; otherwise continue treatment for 10 days. lactational mastitis clindamycin    

If infection does not resolve with antibiotic therapy, evaluate the patient for an abscess and consider whether infection is caused by another pathogen.

If the patient has severe cellulitis, see Cellulitis associated with systemic features for initial treatment. Switch to oral therapy (as above) when symptoms are resolving.

1 Cefalexin may be used in patients who have had a nonsevere (immediate or delayed) reaction to amoxicillin or ampicillin. However, because cross-reactivity between these drugs is possible, consideration should be given to the extent of the reaction, patient acceptability, and the suitability of non–beta-lactam options.Return
2 Severe immediate hypersensitivity reactions include anaphylaxis, compromised airway, airway angioedema, hypotension and collapse. Severe delayed hypersensitivity reactions include cutaneous adverse drug reactions (eg drug rash with eosinophilia and systemic symptoms [DRESS], Stevens–Johnson syndrome/toxic epidermal necrolysis [SJS/TEN], severe blistering or desquamative rash), and significant internal organ involvement (eg acute interstitial nephritis).Return